PureTech appoints Robert Lyne as permanent CEO
18th Dec 2025 08:43
(Sharecast News) - PureTech Health announced the appointment of Robert Lyne as chief executive officer and a member of its board with immediate effect on Thursday.
Read morePureTech Health contract revenues surge, cuts costs as portfolio strategy evolves
28th Aug 2025 07:35
(Sharecast News) - Biotherapeutics firm Puretech Health said on Thursday that it had made "meaningful progress" across its portfolio in the first half of 2025, with contract revenues soaring throughout the period.
Read morePureTech launches respiratory development vehicle Celea Therapeutics
12th Aug 2025 12:04
(Sharecast News) - PureTech Health announced the launch of Celea Therapeutics on Tuesday, a new company focused on developing treatments for serious respiratory diseases, led by former Teva North America chief executive Sven Dethlefs.
Read morePureTech Health CEO Bharatt Chowrira steps down
16th Jul 2025 07:44
(Sharecast News) - Clinical-stage biotherapeutics company PureTech Health said on Wednesday that chief executive officer Bharatt Chowrira has stepped down with immediate effect.
Read morePureTech financials improve in a year of clinical, regulatory milestones
30th Apr 2025 10:35
(Sharecast News) - PureTech Health impressed the market with its annual results for 2024, as the company maintained a strong cash position while hitting a number of key clinical and regulatory milestones during the year.
Read moreLondon close: Stocks weaker ahead of key central bank decisions
16th Dec 2024 15:35
(Sharecast News) - London stocks ended lower on Monday as investors adopted a cautious stance ahead of a week filled with major central bank policy decisions.
Read morePureTech hails "exciting" results from lung disease trial
16th Dec 2024 09:30
(Sharecast News) - Clinical-stage biotech group Puretech Health has announced promising results from the trial of its lung disease treatment deupirfenidone, which the lead investigator hailed as "extremely exciting".
Read moreLondon close: Stocks give up gains to finish in the red
21st Oct 2024 15:48
(Sharecast News) - London stocks ended lower on Monday, after the People's Bank of China made bigger-than-expected cuts to loan prime rates, while UK house price growth stagnated.
Read morePureTech's Seaport closes $225m series B round
21st Oct 2024 12:45
(Sharecast News) - PureTech Health announced on Monday that Seaport Therapeutics, a company it founded, has closed an oversubscribed $225m series B financing round.
Read moreLondon close: Stocks rise as US PCE inflation slows
27th Sep 2024 16:58
(Sharecast News) - London stocks closed higher on Friday as investors digested a slowdown in the Federal Reserve's preferred inflation measure.
Read morePureTech receives $29m royalty from Karuna schizophrenia treatment
27th Sep 2024 07:17
(Sharecast News) - Clinical-stage biotherapeutics company PureTech Health has announced that the schizophrenia treatment it developed, which was later sold to Bristol Myers Squibb, has been approved by US regulators, triggering milestone payment and unlocking potential future royalties.
Read morePureTech Health launches $100m tender offer
20th May 2024 10:13
(Sharecast News) - Clinical-stage biotherapeutics company PureTech Health launched a proposed $100m tender offer on Monday, aiming to repurchase shares at a fixed price of 250p each, or £25.00 per American depositary share (ADS).
Read morePuretech Health operating losses narrow in 'landmark year'
25th Apr 2024 10:07
(Sharecast News) - Biotechnology company Puretech Health said on Thursday that 2023 had been "a landmark year" for the group, making "strong strategic and clinical progress".
Read morePureTech founder steps down as CEO to lead SeaPort spin-off
9th Apr 2024 07:48
(Sharecast News) - Clinical-stage biotherapeutics group PureTech has announced that its founding chief executive is to step down to lead SeaPort Therapeutics, a PureTech company she founded that has just raised $100m in Series A financing.
Read morePuretech Health proposes $100m capital return
19th Mar 2024 09:46
(Sharecast News) - Biotherapeutics company PureTech Health has proposed a capital return of $100.0m to its shareholders by way of a tender offer.
Read more